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Abstract Defective Ca2+ handling is a key mechanism underlying hepatic endoplasmic reticulum
(ER) dysfunction in obesity. ER Ca2+ level is in part monitored by the store-operated Ca2+ entry
(SOCE) system, an adaptive mechanism that senses ER luminal Ca2+ concentrations through the
STIM proteins and facilitates import of the ion from the extracellular space. Here, we show that
hepatocytes from obese mice displayed significantly diminished SOCE as a result of impaired
STIM1 translocation, which was associated with aberrant STIM1 O-GlycNAcylation. Primary
hepatocytes deficient in STIM1 exhibited elevated cellular stress as well as impaired insulin action,
increased glucose production and lipid droplet accumulation. Additionally, mice with acute liver
deletion of STIM1 displayed systemic glucose intolerance. Conversely, over-expression of STIM1 in
obese mice led to increased SOCE, which was sufficient to improve systemic glucose tolerance.
These findings demonstrate that SOCE is an important mechanism for healthy hepatic Ca2+ balance
and systemic metabolic control.
DOI: https://doi.org/10.7554/eLife.29968.001
Introduction
The endoplasmic reticulum (ER) is a key cellular organelle coordinating a variety of essential pro-
cesses such as protein synthesis and secretion, lipid biosynthesis, glucose metabolism and redox
reactions. Additionally, ER is the main site of Ca2+ storage in the cell (Gardner et al., 2013; Hotami-
sligil, 2010). Structurally, ER comprises a complex network of membranes spread throughout the
cytoplasm, which establishes physical and functional contacts with many other organelles including
mitochondria, endosomes, lipid droplets and the plasma membrane (Lynes and Simmen, 2011;
Phillips and Voeltz, 2016).
Given its critical role in the cell, the functionality of the ER is tightly monitored by proteins that
can communicate stress signals to other proteins or compartments of the cell in order to restore ER
function. The most well-known adaptive pathway in the ER is the unfolded protein response (UPR),
which has the general goal of restoring ER function by enhancing ER folding capacity, decreasing
protein translation and increasing protein degradation (Gardner et al., 2013; Hetz et al., 2015;
Hotamisligil, 2010; Wang and Kaufman, 2016). Over the past decade it has been widely docu-
mented that chronic stress imposed by excess nutrients and energy leads to ER dysfunction and UPR
activation in a variety of metabolic tissues in both mouse models and obese humans, which is associ-
ated with cellular stress, inflammation, and metabolic dysfunction (Boden et al., 2008;
Gregor et al., 2009; Hotamisligil, 2010; Nakatani et al., 2005; Ozcan et al., 2004; Sharma et al.,
2008; Wang and Kaufman, 2016). Alleviation of ER stress by chemical or molecular chaperones
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dramatically improves metabolic control and insulin sensitivity and reduces inflammation in mouse
models of obesity (Fu et al., 2015; Kammoun et al., 2009; Ozawa et al., 2005; Ozcan et al., 2006)
as well as in humans (Kars et al., 2010; Xiao et al., 2011).
More recently, it has become clear that Ca2+ storage in the ER is compromised in the setting of
obesity and other metabolic diseases (Arruda and Hotamisligil, 2015; Ozcan and Tabas, 2016).
Ca2+ in the ER is essential for chaperone-mediated protein folding and secretion, as well as for the
function of metabolic enzymes. Ca2+ concentration in the ER is tightly regulated by coordinated
action between SERCA, which pumps Ca2+ from the cytosol into the ER lumen, and the IP3 receptor
(IP3R) or Ryanodine receptor, which release Ca2+ from the ER into the cytosol (Clapham, 2007). In
obesity, hepatic SERCA activity is compromised (Fu et al., 2011; Meikle and Summers, 2017;
Rong et al., 2013) while the activity of the IP3R1 Ca2+ channel is increased (Arruda et al., 2014;
Feriod et al., 2017; Wang et al., 2012). These alterations result in decreased ER Ca2+ content, loss
of folding capacity, ER stress, inflammation, impaired insulin action and abnormal glucose metabo-
lism (Arruda and Hotamisligil, 2015). Additionally, in this setting a ‘leaky’ ER contributes to both
higher cytosolic Ca2+ and mitochondrial Ca2+ uptake, which has important implications for cytosolic
Ca2+ signaling and mitochondrial dysfunction seen in metabolic diseases (Arruda et al., 2014;
Feriod et al., 2017; Ozcan et al., 2013; Wang et al., 2012; Xiao et al., 2011). Accordingly, strate-
gies to restore hepatic ER Ca2+ levels, such as overexpression of SERCA or suppression of IP3R,
improve ER function and promote metabolic homeostasis in mouse models of obesity
(Arruda et al., 2014; Feriod et al., 2017; Fu et al., 2011; Wang et al., 2012). In a similar fashion,
administration of compounds that increase ER Ca2+ content and improve ER function, e.g. SERCA
eLife digest Obesity is a chronic metabolic disorder. Some people’s genetics make them more
vulnerable to the condition, and it is generally caused by eating too much and moving too little. The
resulting surplus of nutrients affects the cells and organs of the body in several adverse ways. For
example, excessive nutrients impair a compartment within cells called the endoplasmic reticulum.
This compartment is where many proteins and fats are made and transported. It is also the site for a
lot of metabolic processes, and the main place in the cell where calcium ions are stored. Many
proteins need calcium ions to work properly, including metabolic enzymes. In obesity, the
endoplasmic reticulum becomes less able to store calcium ions.
A protein called STIM1 senses and regulates the levels of calcium ions in the endoplasmic
reticulum. When calcium levels drop, STIM1 moves along the endoplasmic reticulum membrane
towards the part that is next to the cell surface. Here, STIM1 joins up with a calcium channel called
Orai1. The STIM1-Orai1 complex allows calcium ions to enter the cell and replenish its levels in the
endoplasmic reticulum.
Arruda, Pers et al. have now asked if STIM1 is altered in obesity and, if so, whether it contributes
to the endoplasmic reticulum’s inability to maintain proper calcium levels. High-resolution
microscopy and biochemical techniques confirmed that STIM1 is indeed compromised in liver cells
from obese mice. In these cells, STIM1 was found in unusual small clusters. It also could not move
along the endoplasmic reticulum membrane when calcium levels dropped. As a result of these
navigational errors, STIM1 failed to couple with Orai1, meaning less calcium could enter the cell.
Further work identified that a small sugar molecule that is added onto STIM1 in obesity is behind its
reduced ability to move accurately.
Arruda, Pers et al. next created mice that lacked STIM1 in their liver. These mice showed signs of
metabolic abnormalities. Notably, when STIM1 levels were experimentally increased in obese mice,
it restored calcium levels in the endoplasmic reticulum closer to normal, and improved metabolism
too.
Thus, regulating calcium levels in the endoplasmic reticulum via proteins such as STIM1 is
essential for maintaining a healthy metabolism. Interventions to correct calcium levels may have
therapeutic promise to combat metabolic diseases.
DOI: https://doi.org/10.7554/eLife.29968.002
Arruda et al. eLife 2017;6:e29968. DOI: https://doi.org/10.7554/eLife.29968 2 of 26
Research article Cell Biology Human Biology and Medicine
B. WT Lep
ob/ob 
STIM1 
STIM2 
pJNK 
pCamKII 
Orai1 
β-tubulin 
β-tubulin 
E. 
I. 
WT   
Tg 10 min 
WT   
Tg 30 min 
C. D. 
M
id
d
le
 
STIM1 
Lepob/ob NT 
Lepob/ob  
Tg 10 min 
M
id
d
le
 
Lepob/ob  
Tg 30 min 
B
o
tt
o
m
 
B
o
tt
o
m
 
WT NT 
M
id
d
le
 
M
id
d
le
 
STIM1 
    TIRF WT 
Na+K+ATPase STIM1 
  
STIM1 inset 
  
N
T
 
T
g
 
    TIRF Lep ob/ob 
Na+K+ATPase STIM1 inset 
  
STIM1 
  
STIM1 inset 
  
STIM1 inset 
  
0 50 100 150 200
0
2000
4000
6000
WT NT
WT Tg 10min
WT Tg 30min
Distance (pixels)
P
ix
e
l 
in
te
n
s
it
y
WT 
G. 
J. 
S
T
IM
1
 t
ra
n
s
lo
c
a
ti
o
n
 
cell 
middle 
bottom 
0 200 400 600
0.5
1.0
1.5
2.0
WT
WT + 2-APB
Lepob/ob
Lepob/ob + 2-APB
0 Ca2+2mM Ca2+ 2mM Ca2+
1µM Tg
Time - sec
F
u
ra
-2
A
M
 r
a
ti
o
(n
o
rm
a
li
z
e
d
 t
o
 b
a
s
e
li
n
e
)
A. 
1.0
1.5
2.0
2.5
*
*
WT
Lepob/ob
SOCETg
P
e
a
k
 h
e
ig
h
t
0.0
0.5
1.0
1.5
2.0
STIM1 STIM2 Orai1
WT
Lepob/ob
A
rb
it
ra
ry
 U
n
it
s
 (
a
.u
.)
(n
o
rm
a
li
z
e
d
 β
-t
u
b
u
li
n
 )
0
100
200
300
400
WT 
Lepob/ob
Bottom Middle
*
#
P
u
n
c
ta
 N
u
m
b
e
r
B
a
s
e
li
n
e
0
1000
2000
3000
4000
#
*
WT Lep ob/ob
NT
Tg 30min
Tg 10min
ns
C
o
u
n
ts
F. 
0 50 100 150 200
0
2000
4000
6000
Lep ob/ob  NT
Lep ob/ob Tg 10min 
Lep ob/ob  Tg 30min
Distance (pixels)
P
ix
e
l 
in
te
n
s
it
y
Lepob/ob 
0
2
4
6
WT
Lepob/ob
*
*
**
Tg     0'  10'  30'   0'  10'  30'
E
d
g
e
/C
y
to
s
o
l 
s
ig
n
a
l
cytosol 
H. 
Figure 1. Obesity leads to decreased SOCE and impaired STIM1 translocation in primary hepatocytes. (A) Left panel: representative Fura-2AM based
cytosolic Ca2+ measurements in primary hepatocytes isolated from wild type (WT) and leptin-deficient (Lepob/ob) obese mice. ER Ca2+ stores were
depleted with 1 mM thapsgargin (Tg), a SERCA inhibitor. SOCE was evaluated by substituting the extracellular media (0 mM Ca2+) with media
containing 2 mM Ca2+. Dashed lines show Ca2+ measurements in the presence of 50 mM 2-Aminoethoxydiphenyl borate (2-APB). Right panel:
Figure 1 continued on next page
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agonists (Kang et al., 2016), IP3R antagonists (Ozcan et al., 2012), or azoromide (Fu et al., 2015),
improves metabolic health in obese mice.
In addition to SERCA and IP3Rs, Ca2+ homeostasis in the ER is sensed and regulated by a third
major adaptive/homeostatic system orchestrated by the STIM-Orai complex. STIM proteins (STIM1
and STIM2) are found in the ER and sense luminal Ca2+ through N-terminal Ca2+ binding EF hand
domain. In the resting state, STIM proteins are bound to Ca2+ and spread evenly throughout the ER
membrane. Upon ER Ca2+ release, STIM forms oligomers (seen in confocal microscopy as puncta),
which translocate to junctions between ER and plasma membrane (PM), where they couple with the
PM channel protein Orai1. This coupling results in the import of Ca2+ from the extracellular compart-
ment to the cytosol, providing spatial Ca2+ signals that then influence cellular signaling and promote
Ca2+ replenishment into the ER lumen through SERCA, in the process known as store operated Ca2+
entry or SOCE (Feske, 2007; Prakriya and Lewis, 2015; Soboloff et al., 2012; Wu et al., 2007).
Given that obesity leads to impaired ER Ca2+ handling and this is a key mechanism associated
with ER dysfunction in the obese condition, we examined whether alterations in SOCE system exist
and contribute to the inability of ER to restore and or maintain Ca2+ levels. Here we show that
STIM1 is modified and SOCE is defective in hepatocytes from obese mice due to the inability of
STIM1 to translocate and couple with Orai1 at the PM. Hepatocytes lacking STIM1 displayed stress,
increased glucose production and insulin resistance, whereas over-expression of STIM1 in the liver of
obese mice significantly improved glucose intolerance. These findings support a critical role for
STIM1-mediated SOCE in the maintenance of healthy Ca2+ balance in the ER, insulin action, and sys-
temic glucose metabolism.
Figure 1 continued
quantification of Tg-induced Ca2+ release (reflecting ER Ca2+ content) and SOCE based on the measurements shown in (A), n = 160 WT and n = 250
Lepob/ob cells for Tg response and n = 234 WT and n = 303 Lepob/ob cells for SOCE response. Data were pooled across six independent experiments.
*p<0.0001 (B) Left panel: Immunoblot analysis of protein expression levels in total liver lysate from WT and Lepob/ob mice, Right panel: quantification of
the western blots n = 4, representative of 4–5 experiments. (C and D) Confocal images of immunofluorescence staining for endogenous STIM1 in
primary hepatocytes from WT and Lepob/ob animals, treated with DMSO (vehicle, NT) or 1 mM Tg for 10 and 30 min. NT refers to ‘not Tg treated’ (E)
Quantification of STIM1 puncta/cluster number in the bottom and middle cross-section of non-treated (DMSO) hepatocytes from WT and Lepob/ob
animals.n = 5–6 fields (WT) and 4–5 fields (Lepob/ob), representative of 4 independent experiments, *p=0.02 #p=0.003 (F) Quantification of pixel intensity
in a set area (125  125 pixels) of the middle section of the cells from WT and Lepob/ob animals, treated with 1 mM Tg or vehicle (quantification
methods depicted in Figure 1—figure supplement 1 F), n = 4–9 cells, representative of 4 independent experiments, *p=0.02 #p=0.008 (G)
Representative profile plots of STIM1 levels (pixel intensities) in a defined area (box) across cells treated with DMSO or 1 mM Tg for 10 or 30 min. Left:
cells from WT animals, right: cells from Lepob/ob animals. (H) Quantification of STIM1 translocation by calculating the ratio between the mean STIM1
pixel intensity at a selected area of the edge of the cell relative to the same measurement performed in the cytosolic area near the edge of the cell,
n = 3–4 ratios per cell, quantified in 2–8 cells for each condition *p<0.0001 **p=0.009 (I and J) Representative TIRF images of STIM1 and Na+K+-ATPase
(PM marker) in cells from WT (I) and Lepob/ob mice (J) treated with 1 mM Tg or vehicle for 10 min. NT refers to “not Tg treated. For all graphs, error bars
denote s.e.m. Scale: 10 mm.
DOI: https://doi.org/10.7554/eLife.29968.003
The following source data and figure supplements are available for figure 1:
Source data 1. Source data for Figure 1.
DOI: https://doi.org/10.7554/eLife.29968.004
Figure supplement 1. Obesity leads to impaired STIM1 translocation in primary hepatocytes.
DOI: https://doi.org/10.7554/eLife.29968.005
Figure supplement 1—source data 1. Source data for Figure 1—figure supplement 1.
DOI: https://doi.org/10.7554/eLife.29968.006
Figure supplement 2. Decline of STIM1 trafficking in primary hepatocytes over the course of high fat diet (HFD)
DOI: https://doi.org/10.7554/eLife.29968.007
Figure supplement 2—source data 1. Source data for Figure 1—figure supplement 2.
DOI: https://doi.org/10.7554/eLife.29968.008
Figure supplement 3. Confocal images of immunofluorescence staining of endogenous STIM2 in primary hepatocytes from WT and Lepob/ob animals,
treated with or without 1 mM Tg for 10 min.
DOI: https://doi.org/10.7554/eLife.29968.009
Figure supplement 3—source data 1. Source data for Figure 1—figure supplement 3.
DOI: https://doi.org/10.7554/eLife.29968.010
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Results
In order to determine the impact of obesity on SOCE in the liver, we isolated primary hepatocytes
from lean wild-type (WT) and genetically obese (Lepob/ob) mice and measured Ca2+ influx through
STIM/Orai1 using the ratiometric calcium dye, Fura-2AM (Poenie and Tsien, 1986). First, the cells
were incubated in Ca2+-free medium, and ER Ca2+ store depletion was induced by the addition of
the SERCA inhibitor thapsigargin (Tg). In agreement with earlier reports (Arruda et al., 2014) the ini-
tial rise in cytosolic Ca2+ induced by Tg, which reflects the ER Ca2+ content, was significantly lower
in hepatocytes isolated from obese animals compared with WT cells (Figure 1A). Next, we induced
SOCE through STIM/Orai1 by substituting the Ca2+-free media with a media containing 2 mM Ca2+.
As depicted in Figure 1A, the Ca2+ entry in primary hepatocytes from obese mice was markedly
reduced relative to control cells. To further confirm that the observed Ca2+ entry was mediated by
SOCE, we added the SOCE inhibitor 2-apb, which completely blocked Ca2+ influx in both genotypes
(Figure 1A, dotted lines). This finding is consistent with a report of impaired SOCE in the steatotic
hepatocytes from Zucker rats (Wilson et al., 2015).
As we observed impaired SOCE in hepatocytes from obese animals we next evaluated whether
the expression levels of the main SOCE components were altered in obesity. As shown in Figure 1—
figure supplement 1A, we did not detect differences in expression of Orai1 in the livers of mice
with genetic or high-fat diet (HFD)-induced obesity. Despite a modest increase in the mRNA levels
of stim1 and stim2, protein levels of STIM1, STIM2 and Orai1 remained unchanged in the livers of
mice with both genetic and diet induced obesity (Figure 1B and Figure 1—figure supplement 1B).
However, phospho-JNK (pJNK), a marker of inflammatory stress (Hirosumi et al., 2002) and phos-
pho-Calmodulin kinase (pCaMKII), a marker of elevated cytosolic Ca2+ (Ozcan et al., 2012), were
increased in the livers of obese animals (Figure 1B and Figure 1—figure supplement 1B). Thus
decreased Ca2+ import through SOCE in hepatocytes derived from obese mice appears to be inde-
pendent of the expression levels of critical SOCE components.
We therefore asked whether the decreased Ca2+ import through SOCE in hepatocytes from
obese mice was a result of a functional alteration in STIM1 translocation in the ER membrane. To
evaluate the activity of STIM1 proteins in obesity, we first validated antibodies for endogenous
immunostaining (Figure 1; Figure 1—figure supplement 1C). Next, we isolated primary hepato-
cytes from lean and obese mice, induced Ca2+ store depletion with Tg and determined STIM1 locali-
zation by immunostaining. As shown in Figure 1C and D and Figure 1—figure supplement 1D,
while STIM1 was evenly distributed in the ER membrane of resting cells, Tg treatment led to a dra-
matic translocation to areas of the ER membrane in close proximity with the PM. This effect was
observed within 5–10 min of Tg treatment and persisted for 30 min. However, in cells from obese
(Lepob/ob) mice, STIM1 distribution at baseline was punctate throughout the entire ER (Figure 1D
and quantified in Figure 1E), and its translocation to areas of ER/PM junction in response to Tg was
dramatically impaired. As shown in Figure 1F and Figure 1—figure supplement 1E, in WT cells, Tg
treatment increased the number of high-intensity pixels, indicating the formation of the punctate
structures, which represent oligomerization of STIM proteins. In contrast, hepatocytes derived from
obese mice displayed higher intensity pixel counts at baseline with no further increase following Tg
treatment. Defective STIM1 translocation in hepatocytes from obese animals is also illustrated in the
line graphs showing the representative intensity profile of individual cells before and after Tg treat-
ment (Figure 1G and also see Figure 1—figure supplement 1F for image analysis details). In WT
cells, Tg treatment increased the signal intensity at the edge of the cell and decreased it in the cyto-
sol, quantified as the STIM1 ratio between these compartments (Figure 1H). In hepatocytes from
obese mice, the average signal intensity at baseline was higher than in WT cells, and did not change
significantly in response to Tg (Figure 1H), indicating that STIM1 translocation is markedly defective
in these cells.
To examine STIM1 translocation after Tg stimulation in more detail and using an alternative ana-
lytical tool, we performed total internal reflection fluorescence (TIRF) microscopy, in which fluoro-
phores in the vicinity of the cell surface are selectively excited. As shown in Figure 1I, in WT cells Tg
treatment induced STIM1 puncta formation and accumulation in areas close to the PM. This
response was diminished in cells derived from obese animals (Figure 1J). In these experiments,
Na+K+ ATPase was used as a constitutive marker of PM and its staining pattern did not change in
the presence of Tg.
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We also evaluated the time course of the defect in STIM1 trafficking during the development of
obesity in mice. As shown in Figure 1—figure supplement 2A and Figure 1—figure supplement
2B, after 3 and 5 weeks of HFD, STIM1 showed some degree of translocation towards the plasma
membrane in resting cells, indicating that short term HFD exposure is sufficient to trigger ER Ca2+
release, the driving force for STIM1 translocation. Additionally, at 3 weeks HFD, STIM1 translocation
stimulated by Tg was not significantly impaired compared with cells derived from chow fed animals.
However, the defect in STIM1 translocation induced by Tg was apparent in cells isolated from mice
fed a HFD for 5 weeks and was more pronounced after 7 and 11 weeks of HFD (Figure 1—figure
supplement 2A and Figure 1—figure supplement 2B). These data support that defective STIM1
translocation may be a common feature of obesity in independent experimental models (Lepob/ob
and HFD) and that this phenotype occurs independent of blood glucose levels and prior to the
emergence of marked hyper-insulinemia and insulin resistance found in obesity (Figure 1—figure
supplement 2C).
Next, we examined the activation and translocation of STIM2 in cells from lean (WT) and obese
(Lepob/ob) mice. The role of STIM2 in the regulation of SOCE has been explored only recently, and
its activation seems to result from smaller fluctuations in Ca2+ due to its lower affinity for the ion,
while STIM1 is activated when the extent of ER depletion increases (Berna-Erro et al., 2017; Oh-
Hora et al., 2008; Prakriya and Lewis, 2015). In hepatocytes, STIM2 is expressed at a lower level
than STIM1 (Lo´pez et al., 2012; Williams et al., 2001), however it was detectable both by staining
and by western blot analysis. We did not observe aberrant STIM2 puncta formation in cells from
Lepob/ob mice but a tendency for translocation at baseline. Upon Tg-induced store depletion, we
observed a marked STIM2 translocation to areas close to the PM in both WT cells and Lepob/ob cells,
however the degree of translocation in Lepob/ob cells was less pronounced than in WT cells (Fig-
ure 1—figure supplement 3A). Thus, the obesity-related defect in STIM2 translocation was present
but less dramatic than that observed for STIM1. Overall, these findings suggest that defective SOCE
in primary hepatocytes from obese mice is predominantly related to aberrant STIM1 puncta forma-
tion and inefficient STIM1 re-localization from the bulk ER membrane to ER/PM junction areas after
ER Ca2+ store depletion.
In order to gain insight into mechanisms underlying this phenomenon, we considered the possibil-
ity that altered STIM1 post-translational modification could be involved in its defective translocation
capacity in the context of obesity. Two known post-translational modifications of STIM1 which influ-
ence its trafficking are phosphorylation and O-GlcNAcylation (Pozo-Guisado et al., 2013; Zhu-
Mauldin et al., 2012). Phosphorylation of STIM1 at Ser621 and Ser575 regulate its interaction with
the microtubule plus-end-tracking protein EB1, enabling STIM1 to move in the ER membrane (Pozo-
Guisado et al., 2013). Therefore, we asked whether a reduction in STIM1 phosphorylation at these
sites may explain its defective trafficking in obesity. Surprisingly however, we found that phosphory-
lation of STIM1 at Ser621 and Ser575 was actually increased in liver lysates from obese mice
(Figure 2A). This indicates that lack of phosphorylation at these residues does not underlie the
defective translocation of STIM1, and suggests that hepatic STIM1 may be released from EB1 in the
basal state, potentially as a response to the decreased ER Ca2+ level observed in hepatocytes from
obese mice.
STIM1 can also be modified by O-linked N-acetyl glucosamine (O-GlcNAc), a post-translational
modification of serine or threonine amino acids. Previous work has shown that STIM1 O-GlcNAcyla-
tion impairs the ability of the protein to move in the ER membrane and to form punctate structures
(Zhu-Mauldin et al., 2012). Additionally, conditions of nutrient and substrate excess, including obe-
sity, lead to increase in cellular O-GlcNAcylation levels (Vosseller et al., 2002; Yang and Qian,
2017; Dentin et al., 2008; Yang et al., 2008). These studies indicate the possibility that metabolic
stress may interfere with SOCE via O-GlcNAcylation of STIM1, which disrupts its proper trafficking.
To test this hypothesis, we first examined global O-GlcNAcylation in primary hepatocytes from WT
and obese mice. As shown in Figure 2B, and in agreement with previous observations
(Baldini et al., 2016), global O-GlcNAcylation was higher in hepatocytes derived from obese animals
compared with their controls. This effect was amplified by treatment with PugNac, a specific inhibi-
tor of O-GlycNAcase (OGA), the enzyme that catalyzes removal of OglcNAc sugars from proteins.
Next, we performed immunoprecipitation of O-GlcNAc-modified proteins using an OglcNAc-specific
antibody from hepatocyte lysates. We found that STIM1 was present among the OglcNAcylated pro-
teins and it was more abundant in cells from obese mice (Figure 2C). As a complementary approach,
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Figure 2. Post-translational modification of STIM1 by phosphorylation and O-GlcNAcylation in obesity. (A) Immunoblot analysis of the phosphorylation
level of STIM1 at Ser575 and Ser621 and of ERK phosphorylation in total liver lysates from WT and Lepob/ob animals (B) Immunoblot analysis of
O-GlcNAcylation of total lysates extracted from primary hepatocytes derived from WT and Lepob/ob animals in the presence or absence of overnight
treatment with 10 mM of PugNac, an inhibitor of O-GlcNAcase. (C) Immunoprecipitation of O-GlcNAcylated proteins derived from WT and Lepob/ob
hepatocytes followed by immunoblotting for STIM1. Cells from STIM1-deficient mice (STIM1DLiver) were used as a negative control. (D) Total lysates
from WT or Lepob/ob hepatocytes treated or not with 10 mM of PugNac overnight were incubated with biotinylated, succinylated WGA and precipitated
Figure 2 continued on next page
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we utilized biotinylated-succinylated wheat germ agglutinin (succinylated-WGA), a lectin that prefer-
entially binds N-acetylglucosamine versus other sugars (Baldini et al., 2016; Hu et al., 2010). Fol-
lowing precipitation with streptavidin-conjugated magnetic beads, STIM1 was detected in the pool
of proteins modified by O-GlcNac at higher levels in samples derived from obese animals relative to
WT controls (Figure 2D). Additionally, as shown in Figure 2E, OGT precipitates with STIM1 in hepa-
tocytes derived from obese animals, indicating that OGT and STIM1 exist in a complex in obesity,
consistent with higher levels of O-GlcNac-modified STIM1 in this condition. To explore whether
STIM1 is also modulated by OglcNAcylation in the HFD context and study the time course of this
modification, we isolated hepatocytes from animals fed a HFD for 3, 5 and 11 wks and pull down
STIM1 using succinylated-WGA. As shown in Figure 2—figure supplement 1A, STIM1 was progres-
sively modified by O-GlcNac in this context starting at 3 weeks on HFD.
In order to test if O-GlcNAc modification may alter STIM1 function in hepatocytes, we first over-
expressed OGT in Hepa1-6 cells. As expected, overexpression of OGT strongly increased global
protein modification with O-GlcNac (Figure 2—figure supplement 1B). We then co-expressed OGT
and STIM1 tagged with a Flag peptide (Figure 2—figure supplement 1C) to determine whether
STIM1 can be directly O-GlcNacylated by OGT in this system. Immunoprecipitation of STIM1-Flag
with a Flag specific antibody demonstrated its enhanced O-GlcNAc modification in OGT overex-
pressing cells (Figure 2F). Additionally, STIM1 is able to directly bind to OGT in this cell model
(Figure 2F), similar to what we observed in hepatocytes derived from obese animals (Figure 2E).
Having established this cellular system with enhanced STIM1 O-GlcNacylation, we then assessed its
translocation in cells transfected with OGT labeled with RFP, using un-transfected cells in the same
culture plate as internal controls for quantification (Figure 2G). These experiments showed that
STIM1 puncta formation and translocation following Tg treatment was markedly impaired in cells
overexpressing OGT compared with control cells (Figure 2G,H and I). Additionally, overexpression
of OGT led to a significant impairment in SOCE compared with the controls (Figure 2J), with no sig-
nificant differences in the response to Tg (data not shown).
Next, to determine whether inhibition of the O-GlcNac modification could rescue STIM1 translo-
cation defect in Lepob/ob cells, we used adenoviral gene delivery to express an shRNA targeting
OGT to down-regulate OGT and thus the O-GlcNacylation capacity of the cell. As can be seen in
Figure 2K and L, the expression of OGT shRNA lead to a 60% decrease in its expression and activ-
ity. As shown in Figure 2M and N, down-regulation of OGT resulted in increased STIM1 transloca-
tion capacity compared with cells expressing a scrambled shRNA. Taken together these data
Figure 2 continued
with streptavidin-conjugated beads. The recovered proteins were used for immunoblotting for STIM1. An aliquot of each precipitate was run in a gel
and silver stained. (E) Immunoprecipitation of STIM1 in total lysates from primary hepatocytes derived from WT and Lepob/ob animals followed by
immunoblotting for OGT. Input for OGT and STIM1 in the total lysates prior to immunoprecipitation is shown (F) Immunoprecipitation of STIM1-Flag
from total lysates stably expressing STIM-Flag in the presence or absence of OGT followed by immunoblotting for O-GlcNac and OGT. (G) Confocal
images of endogenous immunofluorescent staining of STIM1 in Hepa1-6 cells transfected with OGT, treated with DMSO or 1 mM Tg stimulation. Non-
transfected cells present in the same dish were used as controls for quantification. OGT expressing cells were identified by the presence of RFP
expression. NT refers to ‘not Tg treated’ (H) Number of STIM1 puncta quantified per cell, n = 7–14 cells per group, representative of 3 independent
experiments, *p=0.0003 #p=0.03. (I) Quantification of STIM1 translocation by calculating the ratio between STIM1 protein signal at the edge of cell
relative to the cytosol close by. For OGT n = 60–64 areas and for OGT +n = 22–30 areas per group, representative of 3 independent experiments,
*p<0.0001 #p=0.004 (J) Left panel: representative Fura-2AM based cytosolic Ca2+ measurements in Hepa1-6 cells overexpressing pcDNA control or
OGT. Right panel: quantification of Ca2+ influx through SOCE. n = 51 (pcDNAt +DMSO) n = 61 (OGT +PugNAc) *p=0.0007. (K and L) Immunoblot
analysis and densitometric quantification of OGT and OglcNAc expression in primary hepatocytes from Lepob/ob animals infected with adenovirus
expressing scrambled shRNA (shSCR) and shRNA against OGT (shOGT) for 48 hr. (M) Confocal images of immunofluorescence staining for endogenous
STIM1 in primary hepatocytes from Lepob/ob animals expressing scrambled shRNA (shSCR) and shRNA against OGT (shOGT) for 48 hr. NT refers to ‘not
Tg treated’ (N) Quantification of STIM1 translocation by calculating the ratio between the mean STIM1 pixel intensity at a selected area of the edge of
the cell relative to the same measurement performed in the cytosolic area near the edge of the cell, n = 3 ratios per cell, 5 cells per field in four fields
per condition,*p=0.04 # p<0.001.For all graphs, error bars represent s.e.m. Scale: 10 mm.
DOI: https://doi.org/10.7554/eLife.29968.011
The following figure supplement is available for figure 2:
Figure supplement 1. STIM1 O-GlcNAcylation in primary hepatocytes and Hepa 1-6 cells.
DOI: https://doi.org/10.7554/eLife.29968.012
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Figure 3. STIM1 deficiency leads to increased cellular stress, insulin resistance and lipid droplet accumulation. (A) Left panel: representative Fura-2AM-
based cytosolic Ca2+ measurements in primary hepatocytes isolated from stim1fl/fl and stim1DLIVER mice. Right panel: quantification of Tg-induced Ca2+
release (reflecting ER Ca2+ content) and SOCE. Error bars denote s.e.m. n = 98 WT and n = 116 stim1DLIVER for Tg response and n = 69 stim1fl/fl and
n = 101 stim1DLIVER for SOCE. Cells were pooled across four independent experiments. *p<0.0001 (B) Immunoblot analysis and quantification of the
expression levels of stress markers in primary hepatocytes isolated from stim1fl/fl and stim1DLIVER mice. n = 6 samples in each group, pooled across
Figure 3 continued on next page
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indicate that increased modification of STIM1 by OglcNAc could, at least in part, underlie defective
STIM1 translocation and reduced hepatic SOCE in the context of obesity.
We then started to investigate the impact of defective STIM1-mediated SOCE on ER homeosta-
sis, cellular stress responses and metabolic regulation in STIM1-deficient hepatocyte cell models.
These included primary hepatocytes derived from mice with genetic STIM1 deficiency specifically in
the liver (stim1fl/fl Alb;Cre, identified here as stim1DLIVER) and Hepa1-6 cells stably expressing
shRNAs targeting stim1 (Figure 3—figure supplement 1A) or stim2 (Figure 3—figure supplement
1B) (identified here as shSTIM1 and shSTIM2 respectively). Primary hepatocytes derived from stim1-
DLIVER mice displayed lower ER Ca2+ content and absence of Tg-triggered SOCE compared to con-
trols (stim1fl/fl) (Figure 3A). Similarly, Hepa 1–6 cells in which STIM1 expression was down regulated
showed markedly blunted SOCE (Figure 3—figure supplement 1C). Imbalances in ER Ca2+ content
trigger cellular stress responses through various pathways (Arruda and Hotamisligil, 2015;
Fu et al., 2012; Ozcan and Tabas, 2016). In order to examine these responses in our cellular models
of STIM deficiency, we measured phosphorylation of JNK as a benchmark measure of cellular stress
and inflammatory activation, and phosphorylation of eIF2a as a marker of UPR activation. As shown
in Figure 3B, in stim1fl/fl control cells, treatment with Tg induced phosphorylation of JNK and eIF2a
at 30 min followed by a decrease in phosphorylation levels back to baseline after 90 min. However,
in STIM1-deficient cells, the phosphorylation of JNK and eIF2a was enhanced at baseline and these
cells displayed a stronger and more persistent response to Tg, with stress markers only returning to
basal levels at 120 min. A similar profile was observed in Hepa1-6 cells with shRNA-mediated sup-
pression of STIM1 (Figure 3—figure supplement 1D). Interestingly, suppression of STIM2 alone did
not alter the cellular response to Tg (Figure 3—figure supplement 1E). Altogether, these data dem-
onstrate that absence of core components of SOCE leads to elevated and prolonged stress
responses in hepatocytes.
Increased cellular stress and inflammation are associated with impaired insulin action and defec-
tive glucose and lipid metabolism (Fu et al., 2012; Hirosumi et al., 2002; Hotamisligil, 2017).
Accordingly, we found that primary hepatocytes derived from stim1DLIVER mice displayed impaired
phosphorylation of IRb and AKT in response to insulin relative to cells from stim1fl/fl littermates
(Figure 3C). Likewise, gene silencing of stim1 in Hepa1-6 cells resulted in decreased insulin signaling
Figure 3 continued
three independent experiments for pJNK and n = 2 for peIF2a, *p=0.0138 #p<0.0001. (C) Immunoblot analysis and quantification of insulin signaling
before and after 3 nM insulin (Ins) treatment for the indicated time points in primary hepatocytes isolated from stim1fl/fl and stim1DLIVER mice. n = 4–5
samples in each group, pooled across two independent experiments for pIR. *p=0.011 and pAKT *p=0.03 and #p=0.0088 (D) Primary hepatocytes
isolated from stim1fl/fl and stim1DLIVER animals treated or not with a mixture containing 1 mM Oleic Acid and 40 mM palmitic acid for 16 hr. Lipid
droplets were stained in green with BODIPY and the nucleus in blue with DAPI. Scale: 10 mm. (E) Glucose output derived from primary hepatocytes
isolated from stim1fl/fl and stim1DLIVER mice kept on a HFD, n = 4 stim1fl/fl and n = 4 stim1DLIVER*p=0.046 (F) Schematic representation of the protocol
for adenovirus-mediated transient hepatocyte knockdown of STIM1 (G) Immunoblot analysis of the indicated proteins in total liver lysates derived from
stim1+/+ n = 4 and n = 4 stim1fl/fl mice, both groups expressing liver-specific Cre recombinase (ad Alb;Cre) adenovirus. (H and I) 16 hr fasting blood
glucose levels (H) and insulin (I) in animals of the indicated genotypes. *p=0.0094 stim1+/+ versus stim1fl/fl and #p<0.0001 stim1fl/+ versus stim1fl/fl (J)
Glucose tolerance test (GTT) in stim1+/+, stim1fl/+ and stim1fl/fl animals expressing adenoviral Alb;Cre recombinase *p<0.04; Right panel: quantification
of area under the curve from GTT. n = 5 stim1+/+, n = 6 stim1fl/+, n = 8 stim1fl/fl animals, *p=0.03 stim1+/+, versus stim1fl/fl and #p=0.01 stim1fl/+ versus
stim1fl/fl, representative of 2 independent experiments. For all graphs, error bars denote s.e.m.
DOI: https://doi.org/10.7554/eLife.29968.013
The following source data and figure supplements are available for figure 3:
Source data 1. Source data for Figure 3.
DOI: https://doi.org/10.7554/eLife.29968.014
Figure supplement 1. STIM1 downregulation increases cellular stress and impairs insulin signaling in Hepa 1-6 cells.
DOI: https://doi.org/10.7554/eLife.29968.015
Figure supplement 1—source data 1. Source data for Figure 3—figure supplement 1.
DOI: https://doi.org/10.7554/eLife.29968.016
Figure supplement 2. Effect of liver-specific deletion of STIM1 on metabolic parameters in vivo.
DOI: https://doi.org/10.7554/eLife.29968.017
Figure supplement 2—source data 1. Source data for Figure 3—figure supplement 2.
DOI: https://doi.org/10.7554/eLife.29968.018
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(Figure 3—figure supplement 1F). Additionally, primary hepatocytes isolated from stim1DLIVER mice
maintained on HFD showed higher levels of glucose production stimulated by the gluconeogenesis
substrates glycerol, pyruvate and glutamine compared to stim1fl/fl derived hepatocytes (Figure 3E).
In agreement with our finding that STIM2 suppression does not amplify stress responses, we found
that STIM2-deficient cells retained normal insulin responsiveness (Figure 3—figure supplement 1G).
Recently, it has been shown that SOCE may regulate lipid metabolism (Maus et al., 2017;
Wilson et al., 2015) and animals with inducible STIM1/2 whole body deficiency exhibit increased
lipid accumulation in multiple tissues such as skeletal muscle, heart and liver, as a consequence of
impaired lipolysis and fatty acid oxidation (Maus et al., 2017). We observed that primary hepato-
cytes isolated from stim1DLIVER mice showed modestly increased accumulation of lipid droplets at
baseline and after incubation with 1 mM oleic acid and 40 mM of palmitic acid (Figure 3D). These
results suggest that in addition to higher stress levels, insulin resistance and increased glucose pro-
duction, SOCE deficiency may result in abnormal lipid metabolism.
We next assessed the systemic metabolic impact of STIM1 deficiency in hepatocytes in vivo in the
stim1DLIVER mice described above. As shown in Figure 3—figure supplement 2A, liver lysates from
stim1DLIVER mice displayed marked reduction in STIM1 and a mild increase in STIM2 protein. On a
chow diet, stim1DLIVER mice gained weight equivalently to stim1fl/fl mice (Figure 3—figure supple-
ment 2B) and did not exhibit alterations in glucose tolerance and triglyceride content (Tg) (data not
shown). In the HFD-fed mice, the weight gain was similar between genotypes (Figure 3—figure sup-
plement 2B). Interestingly, at 6 weeks on a HFD, we observed a mild, but significant, glucose intol-
erance in the stim1DLIVER animals compared with the stim1fl/fl controls (Figure 3—figure
supplement 2C). Additionally, at this time point, insulin sensitivity was impaired (Figure 3—figure
supplement 2D). No significant differences were observed in Tg content between the two geno-
types, although a tendency to higher Tg levels was detected in stim1DLIVER mice (Figure 3—figure
supplement 2E). In long term HFD (20 weeks), the differences in glucose intolerance, insulin signal-
ing and Tg content between stim1fl/fl and stim1DLIVER groups were very mild and did not reach statis-
tical significance (Figure 3—figure supplement 2F,G and H).
Interestingly, although we haven’t observed overall changes in lipid accumulation in the liver spe-
cific STIM1 deficient animals, we have noticed that these animals showed higher content of microve-
sicular steatosis compared with controls where the majority of the lipid droplets are presented as
large droplets (Figure 3—figure supplement 2I).
In light of the mild in vivo metabolic phenotype of constitutive hepatocyte-specific STIM1 dele-
tion during development, we considered that STIM2 upregulation (Figure 3—figure supplement 2)
or alternative systems could compensate for the lack of STIM1 all throughout the embryonic life.
Therefore, we examined the effect of acute deletion of STIM1 in hepatocytes, using adenovirus
mediated gene delivery to express albumin-Cre recombinase (Alb;Cre) in adult stim1+/+ and stim1fl/fl
mice. After weaning, littermate animals were subjected to HFD for 4 weeks (for a short-term stress
induction) (Figure 3F). Adenoviral delivery of Alb;Cre recombinase resulted in ~60% deletion of
hepatic STIM1 (Figure 3G). Importantly, there was no compensatory upregulation of STIM2 or Orai1
in this setting. Indeed, one week after adenovirus administration, the acute deletion of STIM1
resulted in significantly higher fasting glucose levels (Figure 3H) without any difference in insulin lev-
els (Figure 3I) and body weight (data not shown). Interestingly, following STIM1 deletion, mice also
exhibited significantly impaired glucose tolerance (Figure 3J). In summary, acute SOCE dysfunction
in the liver results in amplified cellular stress and glucose intolerance in mice fed a HFD.
Based on these observations, and the marked SOCE defect associated with obesity we hypothe-
sized that recovery of SOCE function in the livers of obese mice could improve metabolic homeosta-
sis in obesity. To test this hypothesis, we used a hepatocyte-specific adenovirus system to
exogenously express either GFP (control) or STIM1-YFP in the Lepob/ob primary hepatocytes and
mice (Figure 4A). The functionality of the STIM1-YFP fusion protein has been verified previously
(Liou et al., 2005) and confirmed by us (Video 1).
Using this approach, we asked whether exogenous expression of STIM1-YFP would be sufficient
to overcome the SOCE defects in primary hepatocytes from obese animals. As shown in Figure 4B,
in control Lepob/ob cells expressing GFP, STIM1 formed puncta at baseline and Tg-induced transloca-
tion of the protein was impaired, as we previously observed (Figure 1D). Delivery of STIM1-YFP lead
to a significant increase in the protein level in liver cells. Interestingly, in non treated cells, we
observed that some degree of the STIM1 protein was already localized in areas of close contact with
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Figure 4. Overexpression of STIM1 promotes STIM1 translocation to ER/PM junctions and improves SOCE in primary hepatocytes from obese animals.
(A) Immunoblot analysis of STIM1-YFP expression levels in total lysates from livers isolated from Lepob/ob mice transduced with adenovirus (Ad)
expressing GFP or STIM1-YFP. (B–C) Confocal images of immunofluorescence staining for endogenous STIM1 in primary hepatocytes from Lepob/ob
mice expressing adGFP (B) or adSTIM1-YFP (C) treated with DMSO (vehicle) and 1 mM Tg. NT refers to ‘not Tg treated’. (D) Quantification of STIM1
translocation by calculating the ratio between the mean STIM1 pixel intensity at a selected area of the edge of the cell relative to the same
measurement performed in the cytosol. n = 26 adGFP NT and Tg treated and n = 16 adSTIM1-YFP NT and n = 19 Tg treated *p=0.0023, #p=0.0015.
Scale: 10 mm. (E) Transmission Electron Micrographs of primary hepatocytes isolated from Lepob/ob animals expressing STIM1-HRP, treated with DMSO
or treated 1 mM Tg for 10 min. Scale: 500 nm. (F) Immunoblot analysis and densitometric quantification of OglcNac and STIM1 expression in primary
hepatocytes from Lepob/ob animals infected with AdGFP and AdSTIM1-YFP adenovirus for 24 hr. Quantification reflects the sum of the endogenous and
exogenous STIM1 (G) Left: Representative Fura-2AM-based cytosolic Ca2+ measurements in primary hepatocytes isolated from Lepob/ob animals
expressing adGFP or adSTIM1-YFP. Right: Quantification of Tg-induced Ca2+ release (reflecting ER Ca2+ content) and SOCE measurements . n = 126
adGFP and n = 83 adSTIM1-YFP cells for Tg response and n = 127 adGFP and n = 62 adSTIM1-YFP cells for SOCE, representative of 5 independent
experiments. *p<0.0001. For all graphs. error bars denote s.e.m.
DOI: https://doi.org/10.7554/eLife.29968.019
The following source data and figure supplement are available for figure 4:
Source data 1. Source data for Figure 4.
DOI: https://doi.org/10.7554/eLife.29968.020
Figure supplement 1. Effect of STIM1-YFP overexpression in ER morphology and apposition to the plasma membrane.
DOI: https://doi.org/10.7554/eLife.29968.021
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the plasma membrane even prior to stimulation (Figure 4C). Additionally, exogenously expressed
STIM1 was able to translocate towards the plasma membrane after Tg treatment (Figure 4C and D).
To examine STIM1 translocation in Lepob/ob hepatocytes with higher resolution, we also performed
TEM in cells expressing exogenous STIM1 fused with HRP. STIM1-HRP-expressing cells were fixed
and treated with diaminobenzidine (DAB) in the presence of H2O2. HRP catalyzes the polymerization
and deposition of DAB, which recruits electron-dense osmium, providing contrast and revealing the
localization of STIM1. As shown in Figure 4E, exogenous delivery of STIM1-HRP resulted in rescue
of translocation in cells from obese animals in a manner similar to that observed in lean, wild type
cells. Taken together, these data indicate that exogenously increasing the amount of STIM1 protein
is sufficient to partially overcome the STIM1 translocation defect in cells from obese mice.
The ability of STIM1-YFP overexpression to overcome, at least in part, the translocation defect of
endogenous STIM1 in Lepob/ob cells suggests that at least some proportion of STIM1 in this setting
may escape the O-GlycNac modification. To examine the degree of O-GlcNacylation of overex-
pressed STIM1-YFP in Lepob/ob cells, we used an O-GlcNac specific antibody to immunoprecipitate
all proteins modified by O-GlycNacylation in GFP or STIM1 YFP overexpressing cells and examined
STIM1 protein by immunoblotting. As shown in Figure 4F, STIM1-YFP overexpression resulted in
an ~20 fold increase in the expression of STIM1 protein. However, the amount of O-GlcNac modified
STIM1 did not increase proportionally, indicating that in fact a significant amount of the overex-
pressed STIM1 escapes this post translation modification.
Additionally, it has been previously shown that overexpression of STIM1 in HeLa cells leads to
morphological changes in the ER with an increased cortical ER (Orci et al., 2009). In agreement with
this finding, electron micrographs of primary hepatocytes derived from Lepob/ob mice show that
STIM1-YFP expression led to a remodeling of ER with abundant ER stacks apposed to the PM,
although the degree of ER remodeling varied from cell to cell, likely due to variable STIM1 expres-
sion levels (Figure 4—figure supplement 1A). This result suggests that, in addition to having more
STIM1 that translocates to PM, overexpression of STIM1-YFP also remodels the ER, favoring the
proximity of STIM1 to Orai at the plasma membrane.
After verifying that overexpression of STIM1-YFP was able to rescue STIM1 translocation defects
in obese cells, we examined whether this actually resulted in improved SOCE. As shown in
Figure 4G overexpression of STIM1-YFP in Lepob/ob cells resulted in increased ER Ca2+ and SOCE
compared to control cells. Thus, overexpression of STIM1 was a successful intervention to overcome
the STIM translocation and SOCE defects, resulting in improved ER calcium handling.
Next, we asked whether the effects of the overexpression of STIM1-YFP in Lepob/ob primary hepa-
tocytes would impact overall metabolism in vivo, and evaluated the effect of liver-specific STIM1
expression on systemic glucose metabolism in
the Lepob/ob mice following the protocol dis-
played in Figure 5A. Introduction of STIM1 by
adenovirus gene delivery led to increased STIM1
protein levels in the liver. Interestingly, increased
STIM1 expression was also accompanied by
increased mRNA expression of Orai1 and with an
increase in SERCA (Atp2a2) mRNA and protein
levels (Figure 5B and C). This is in accordance
with previous work showing that the modulation
of expression STIM1 affects the expression of
other Ca2+ channels or pumps, as SERCA, likely
due to alterations in cytosolic Ca2+ levels
(Abell et al., 2011). Remarkably, liver-specific
overexpression of STIM1 led to a significant
improvement in glucose tolerance relative to con-
trol (adGFP) animals as evaluated by a glucose
tolerance test (Figure 5D). Improved glucose tol-
erance resulting from overexpression of STIM1
was associated with enhanced in vivo insulin sig-
naling evaluated by direct insulin injection into
the livers that resulted in increased AKT
Video 1. STIM1-YFP translocation upon thapsigargin
(Tg) treatment. Primary Hepatocytes were infected with
STIM1-YFP, treated with 1 uM Tg and YFP fluoresce
was recorded over the period of time indicated in the
movie.
DOI: https://doi.org/10.7554/eLife.29968.022
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Figure 5. Overexpression of STIM1 leads to improved insulin signaling, glucose tolerance and lipid accumulation in obese animals. (A) Schematic
representation of the protocol for adenovirus mediated STIM1- YFP expression in Lepob/ob mice (B) mRNA expression levels of indicated genes
evaluated by qPCR, normalized to 18S, n = 9 for WT and n = 10 for STIM1-YFP pooled from two independent experiments, *p=0.04 (C) Left panel:
Immunoblot analysis of indicated proteins in liver total lysates from Lepob/ob mice expressing GFP or STIM1-YFP. Right panel: quantifications of the
blots. n = 3 adGFP and n = 4 adSTIM1-YFP, *p=0.001 (D) Glucose tolerance tests in Lepob/ob mice after adGFP (control) and adSTIM1-YFP expression
with quantifications of area under the curve. n = 7 adGFP and n = 11 adSTIM1-YFP animals, representative of 3 independent experiments.*p=0.022 (E)
Markers of in vivo insulin signaling evaluated by immunoblot analysis of total liver lysates from animals injected with insulin (0.75 U/kg) through the
portal vein. Tissues were collected 3 min after injection. Right panel: phospho-protein level quantification normalized to total protein levels. n = 3 for
adGFP and n = 4 for adSTIM1-YFP, *p=0.0003. (F and G) mRNA expression levels of indicated genes evaluated by qPCR, normalized to 18S, n = 9 for
both WT and STIM1-YFP pooled from two independent experiments. *p<0.01 # p<0.04. (H) Liver triglyceride content in Lepob/ob animals expressing
adGFP (control) and adSTIM1-YFP pooled from three independent cohorts. n = 14 adGFP and 17 adSTIM1-YFP, *p=0.042. For all graphs, error bars
denote s.e.m.
DOI: https://doi.org/10.7554/eLife.29968.023
The following source data and figure supplements are available for figure 5:
Source data 1. Source data for Figure 5.
DOI: https://doi.org/10.7554/eLife.29968.024
Figure supplement 1. Effect of STIM1-YFP overexpression in mRNA expression of genes involved in lipolysis and lipogenesis.
DOI: https://doi.org/10.7554/eLife.29968.025
Figure supplement 1—source data 1. Source data for Figure 5—figure supplement 1.
DOI: https://doi.org/10.7554/eLife.29968.026
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phosphorylation (Figure 5E). Additionally, expression of genes involved in glycolysis were increased
in livers overexpressing STIM1, accompanied by decreased levels of PCK1 (PEPCK), a rate limiting
enzyme for gluconeogenesis (Figure 5F and G).
Given the reported role of STIM1 in lipid metabolism, we also evaluated if overexpression of
STIM1 impacted the excessive lipid accumulation in the livers of Lepob/ob animals. As shown in
Figure 5H, exogenous expression of STIM1 led to a reduction in total Tg content in the liver tissue
of Lepob/ob mice compared to controls expressing GFP. Accordingly, STIM1 overexpression led to
increase mRNA expression of genes involved in fatty acid oxidation, such as CPT1, while no change
was observed in genes involved in lipogenesis (Figure 5—figure supplement 1A and B). Based on
these results we conclude that SOCE is critical for glucose and lipid metabolism and that increasing
hepatic SOCE through overexpression of STIM1 is able to revert, at least in part, the deleterious
impact of obesity on systemic glucose homeostasis.
Discussion
In the last several years, a growing number of studies have laid the foundation for the concept that
disrupted intracellular Ca2+ homeostasis in metabolic tissues is a key component of ER dysfunction
and metabolic deterioration (Arruda and Hotamisligil, 2015; Ozcan and Tabas, 2016). The abnor-
mal Ca2+ handling in the ER of hepatocytes in this setting is multi-faceted, involving both impairment
of SERCA activity (Fu et al., 2011) as well as increased activity of IP3R (Arruda et al., 2014;
Feriod et al., 2017;Wang et al., 2012). This impacts not only Ca2+ levels in the ER and protein fold-
ing, but also mitochondrial oxidation and ROS production as well as the activation of cytosolic stress
signaling pathways. Supporting the critical role of this biology, human genetic studies have shown
that SNPs in SERCA (Varadi et al., 1999) and IP3R (Shungin et al., 2015) are associated with meta-
bolic diseases such as obesity and diabetes. Here, our work reveals that another key mechanism sup-
porting ER Ca2+ homeostasis, STIM-mediated SOCE, is also defective in obesity with important
implications for the metabolic dysfunction in hepatocytes. Strikingly, we demonstrate that STIM1
gain-of-function improves cellular stress responses and glucose homeostasis in obese mice, under-
scoring the therapeutic potential of targeting Ca2+ homeostasis through STIM1 for metabolic dis-
ease treatment.
Our interest in this biology was heightened by our initial observation that in hepatocytes isolated
from obese (Lepob/ob) mice, STIM1 was present in an aberrant punctate pattern along the ER mem-
brane. One possible explanation was that Lepob/ob hepatocytes display increased SOCE even in
baseline conditions in order to respond to low ER Ca2+ levels induced by dysfunction of SERCA and
IP3R1. However, our detailed examination revealed that in cells of obese mice, STIM1 puncta were
not localized in areas of close proximity of the PM, but rather were distributed all throughout the
cell away from the PM. Additionally, when we depleted ER Ca2+ stores, STIM1 was not able to fully
translocate to the PM, resulting in significantly reduced SOCE. Hence, metabolic stress impairs this
critical component of ER Ca2+ homeostasis in obese liver tissue.
One question arising from these observations is the nature of the mechanism underlying STIM1
dysfunction in obesity. STIM activation and translocation is modulated by a complex array of factors
that include post-translational modification of the protein itself, protein-protein interactions (for
review Lopez et al., 2016), the interaction of STIM1 with lipids of the ER membrane and the ability
of the ER itself to remodel and form ER/PM junctions (Derler et al., 2016; Lopez et al., 2016;
Prakriya and Lewis, 2015). Here we found that in hepatocytes derived from Lepob/ob mice, STIM1
displays significantly increased levels of O-GlcNAcylation, a post-translation modification that causes
impaired STIM1 trafficking and function (Zhu-Mauldin et al., 2012). Indeed, overexpression of OGT
in hepatocytes was sufficient to induce abnormal STIM1 puncta formation and impaired activation of
SOCE while down-regulation of OGT in primary hepatocytes from obese mice partially rescued the
STIM1 translocation defect. It will be interesting to explore the detailed location and impact of these
modifications in future studies. In silico analysis, published literature and data in dbOGAP, suggest
potential target sites coinciding with the domains involved in STIM1/Orai1 interactions with Orai1 in
the CAD/SOAR domain or in the polybasic motif located at the C terminal of the protein that may
be critical in oligomerization and puncta formation (Liou et al., 2007). Regardless, protein modifica-
tion with O-GlcNAc is a reflection of the nutritional status, as it integrates glucose, amino acid, fatty
acid and nucleotide flux through the hexosamine biosynthetic pathway (HBP) to produce N-acetyl-
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glucosamine (UDP-GlcNAc), the obligatory substrate for OGT. Hence, conditions of nutrient and
substrate excess, including obesity, lead to increased cellular O-GlcNAcylation levels
(Vosseller et al., 2002; Yang and Qian, 2017; Dentin et al., 2008; Yang et al., 2008). Taken
together, our findings demonstrate that O-GlcNAc modification of STIM1 alters organelle Ca2+ regu-
lation with consequences for ER function and systemic metabolism and provide an important mecha-
nistic insight into regulation of this critical metabolic integration point through organelle
homeostasis in obesity.
Another important finding reported here is that impaired SOCE in hepatocytes by STIM1 defi-
ciency was sufficient to induce markers of ER stress and inflammation, to impair of insulin action,
increase glucose production and induce excessive lipid droplet accumulation. Recently, it has been
reported that cells from patients with loss-of-function mutations in STIM1 or ORAI accumulate lipid
droplets as a consequence of their inability to increase cAMP, mobilize fatty acids from lipid drop-
lets, activate lipolysis, and oxidize fatty acids (Maus et al., 2017). Interestingly, tamoxifen-induced
whole body STIM1/2 deficiency leads to higher lipid content in the heart, muscle and liver
(Maus et al., 2017). Here, although we detected increased accumulation of lipid droplets in hepato-
cytes lacking STIM1 in vitro, these phenomena were not clearly observed in vivo. Hepatocyte-specific
deletion of STIM1 led to a mild metabolic phenotype in vivo suggesting that the activation of com-
pensatory systems occurs when STIM1 is deleted during development. Indeed, STIM2 expression
levels were slightly increased in STIM1 deficient liver. Furthermore, in lean animals, the rest of the
ER calcium handling systems are intact, which may allow maintenance of the normal equilibrium. In
contrast, acute down-regulation of STIM1 showed a more marked effect on glucose homeostasis.
Finally, we show here that exogenous expression of STIM1 in primary hepatocytes from obese
mice is sufficient to overcome SOCE defects and partially correct ER Ca2+ levels and STIM1 re-locali-
zation upon Ca2+ store depletion. Notably, we showed that a significant part of the exogenously
expressed STIM1 is able to escape the O-GlcNAc modification, probably by a mass effect, and
responds properly to ER Ca2+ depletion. Additionally, overexpression of STIM1 in hepatocytes from
Lepob/ob animals led to remodeling of the ER with an increase in the amount of cortical ER possibly
facilitating STIM1 translocation and Orai1 coupling. Indeed, it is known that STIM1 regulates the
structure of the ER through its role in Tip Attachment Complex movement (Grigoriev et al., 2008;
Westrate et al., 2015), coordinating the growth and shrinkage of the ER tubule. Importantly, we
show that upregulation of SOCE through STIM1 replenishment in the liver of obese mice results in
significant metabolic benefit including improved insulin signaling and glucose tolerance and
decreased lipid content likely as a result of enhanced fatty acid oxidation. When STIM1 is exoge-
nously supplied to the liver tissue in obese mice, we also observed an increase in glycolytic gene
expression. This is in agreement with recent report showing that in T cells SOCE regulates the
expression of glycolytic genes through the modulation of the transcription factor NFAT
(Vaeth et al., 2017). Overexpression of STIM1 also led to increased SERCA levels, which is necessary
for the delivery of Ca2+ into the ER. In fact, it is proposed and validated experimentally and compu-
tationally that an adaptive feedback loop between components of Ca2+ machinery exist to keep
cytosolic Ca2+ levels under control (Abell et al., 2011). Increased SERCA expression in the context
of STIM1 overexpression may indeed be a critical component of the metabolic benefit resulting from
STIM1 expression in the liver in obese mice. It is remarkable that the individual manipulation of mul-
tiple proteins involved in the maintenance of ER Ca2+ levels- SERCA, IP3R, and STIM1- all result in a
similar phenotype. These findings underscore the importance of ER Ca2+ homeostasis and ER func-
tion to metabolic health, and indicate the strong potential for targeting these pathways to combat
metabolic disease.
Materials and methods
General animal care and study design
All in vivo studies are approved by the Harvard Medical Area Standing Committee on Animals.
Unless stated otherwise, mice were maintained from 4 to 20 weeks on a 12-hour-light/12 hr-dark
cycle in the Harvard T.H. Chan School of Public Health pathogen-free barrier facility with free access
to water and to a standard laboratory chow diet (PicoLab Mouse Diet 20 #5058, LabDiet). No spe-
cific power analysis was used to estimate sample size. The sample size and number of replicates for
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this study were chosen based on previous experiments performed in our lab and others
(Arruda et al., 2014; Fu et al., 2011).
Animal models of obesity
We used two mouse models of obesity, the leptin-deficient Lepob/ob mouse, and HFD-induced obe-
sity. For the former, wild-type mice in the C57BL/6J genetic background (Stock no. 000664) and
Lepob/ob mice (Stock no. 000632) were purchased from Jackson Laboratories at 6–7 weeks of age
and used for experimentation between 8–12 weeks of age. For the latter, male C57BL/6J mice were
purchased from Jackson Laboratories and placed on HFD (D12492: 60% kcal% fat; Research Diets)
for up to 20 weeks. Control mice of the same age were fed with a low fat diet (PicoLab Mouse Diet
20 #5053, LabDiet). In animal experiments, all measurements were included in the analysis unless
they fell more than two standard deviations from the mean.
STIM1 hepatocyte-specific deficient mice
Mice carrying floxed alleles for stim1 (referred here as stim1fl/fl) on a C57BL/6J background were
kindly provided by Dr. Anjana Rao, La Jolla Institute for Allergy and Immunology. To generate hepa-
tocyte-specific STIM deficient mice, stim1fl/fl mice were bred to C57BL/6J mice expressing CRE
recombinase under the control of the albumin promoter (Alb;Cre). Alb;Cre -mediated recombination
of floxed stim1 alleles was detected in genomic DNA by PCR. Age-matched littermates were used
for the study of adult mice. For HFD studies, pups were placed on low-fat control diet (5053) for 1
week at weaning, followed by up to 20 weeks on HFD. The control chow group remained on low-fat
diet. For the adenovirus-mediated stim1 down-regulation study, stim1fl/+ (het) animals were crossed
to each other to generate a group containing stim1+/+, stim1fl/+ and stim1fl/fl homozygous mice.
Pups of the three genotypes were weaned and fed a low-fat diet (5053) for 1 week followed by 4
weeks of HFD. The animals were transferred to a BL2 facility where they received adenovirus-
expressing Alb;Cre-recombinase (1  109 IFU/mouse) intravenously. Metabolic studies were per-
formed between day 7–12 after infection. The animals were sacrificed after 14 days of infection for
ex vivo experiments.
Adenovirus-mediated overexpression of STIM1
For exogenous STIM1 expression, purified, de-salted adenovirus (serotype 5, Ad5) expressing
STIM1-YFP was purchased from Vector BioLabs with the agreement of Dr. Alexei Tepikin from Uni-
versity of Liverpool. The adenovirus was administered to 8–10 week-old Lepob/ob mice intravenously,
at a titer of 1  109 IFU/mouse. Metabolic studies were performed between day 7–12 after infection.
The animals were sacrificed after 14 days of infection for ex vivo experiments.
Glucose tolerance tests
Animals were subjected to an intraperitoneal (i.p.) glucose injection (lean: 1.5 g kg 1, obese: 0.5–1.0
g kg 1) after overnight fasting, and blood glucose levels were measured throughout the first 120
min of the metabolic response.
Liver triglyceride measurements
Liver tissues (approximately 100 mg) were homogenized in 1.2 mL of water. Next, 100 mL of the
homogenate was transferred to a 1.5 mL tube and 125 mL of chloroform and 250 mL of Methanol
were added. Samples were vortexed briefly and incubated for 5 min. Additional 125 mL of chloro-
form was added. Next, 125 mL of water was added and samples were vortexed and centrifuged at
3000 rpm for 20 min at 4˚C. Around 150 mL of the lower phase was collected in a 1.5 mL tube and
dried (evaporated) in a heated vacuum oven. Thereafter, lipids were re-suspended in 300 uL of etha-
nol. Triglyceride in this solution was measured by a Randox Tg Kit (cat number TR213) from Randox
Laboratories.
Primary hepatocyte isolation
Animals were anesthetized using 2 mg/ml xylazine combined with 2 mg/ml ketamine in PBS and the
livers were perfused with 50 mL of buffer I (content described below) through the portal vein with an
osmotic pump set to the speed of ~4 mL/min until the liver turned pale. The speed was gradually
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increased until ~7 mL/min afterwards. When the entire buffer I had been infused, it was substituted
for 50 mL of buffer II. The buffers should be kept at ~37˚C during the entire procedure. After perfu-
sion, the primary hepatocytes were carefully released and sedimented at 500 rpm for 2 min, washed
two times and suspended with Williams E medium supplemented with 5% CCS and 1 mM glutamine
(Invitrogen, CA). To separate live from dead cells, the solution of hepatocytes was layered on a 30%
Percoll gradient and centrifuged ~1500 rpm for 10–15 min. The healthy cells were recovered at the
bottom of the tube and plated for experimentation. Buffer I contained: 11 mM Glucose; 200 mM
EGTA; 1.17 mM MgSO4 heptahydrated; 1.19 mM KH2PO4; 118 mM NaCl; 4.7 mM KCl; 25 mM
NaHCO3, pH 7.32. Buffer II contained: 11 mM Glucose; 2.55 mM CaCl2; 1.17 mM MgSO4 heptahy-
drated; 1.19 mM KH2PO4; 118 mM NaCl; 4.7 mM KCl; 25 mM NaHCO3; BSA (fatty acid free) 7.2
mg/mL; 0.18 mg/mL of Type IV Collagenase (Worthington Biochem Catalog: LS004188). BSA and
collagenase were added immediately before use.
Table 1. List of primers used for qPCR measurements and sequences of the shRNA used in this
study.
List of SYBR green primers for real-time PCR
Gene name Forward primer Reverse primer
stim1 TGAAGAGTCTACCGAAGCAGA AGGTGCTATGTTTCACTGTTGG
stim1 ACAGTGAAACATAGCACCTTCC TCAGTACAGTCCCTGTCATGG
stim2 CGAAGTGGACGAGAGTGATGA GGAGTGTTGTTCCCTTCACATT
orai1 GATCGGCCAGAGTTACTCCG TGGGTAGTCATGGTCTGTGTC
Itpr1 GGGTCCTGCTCCACTTGAC CCACATCTTGGCTAGTAACCAG
Atp2a2 CTGTGGAGACCCTTGGTTGT CAGAGCACAGATGGTGGCTA
Gck ACCAAGCGGTATCAGCATGTG TGGACTTCTCTGTGATTGGCA
Hk2 ATGATCGCCTGCTTATTCACG CGCCTAGAAATCTCCAGAAGGG
Hk3 TGCTGCCCACATACGTGAG GCCTGTCAGTGTTACCCACAA
Pkm GGTGGCTCTGGATACAAAGGG CACACTTCTCCATGTAAGCGT
Gpi CTCAAGCTGCGCGAACTTTTT GGTTCTTGGAGTAGTCCACCAG
Pgm1 CAGAACCCTTTAACCTCTGAGTC TCATTCATTCGAGAAATCCCTGC
Pgm2 GCGGAATGGGATGAACAAGGA GGTCATTGATGTAGCAAAACCCT
Pck1 CTGCATAACGGTCTGGACTTC GCCTTCCACGAACTTCCTCAC
G6pc CTGAGCGCGGGCATCATAAT GATTCTTAGGATCGCCCAGAAAG
Pgc1a CCC TGC CAT TGT TAA GAC C TGC TGC TGT TCC TGT TTT C
Ppara TATTCGGCTGAAGCTGGTGTA CTGGCATTTGTTCCGGTTCT
Cpt1 GCTGGAGGTGGCTTTGGT GCTTGGCGGATGTGGTTC
Slc25a20 AGTCGGACCTTGACCGTGT GACGAGCCGAAACCCATCAG
Scd1 TTC TTG CGA TAC ACT CTG GTG C CGG GAT TGA ATG TTC TTG TCG T
Fas GGA GGT GGT GATA GCC GG TAT TGG GTA ATC CATA GAG CCC AG
Serbpc1 GGAGCCATGGATTGCACATT GGCCCGGGAAGTCACTGT
18S AGTCCCTGCCCTTTGTACACA CGATCCGAGGGCCTCACTA
Oligonucleotides for shRNA
stim1 CCGGCCGAAACATCCATAAGCTGATCTCGA
GATCAGCTTATGGATGTTTCGGTTTTTTG
TRCN0000193877
stim2 CCGGGACGAAGTAGACCACAAGATTCTCG
AGAATCTTGTGGTCTACTTCGTCTTTTTTG
TRCN0000187841
ogt CCGGCCCATTTCTTTCAGCAGAAATCTCGA
GATTTCTGCTGAAAGAAATGGGTTTTTG
TRCN0000110395
DOI: https://doi.org/10.7554/eLife.29968.027
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Glucose production assay
Primary hepatocytes derived from stim1fl/fl and stim1DLIVER animals kept on high fat diet were iso-
lated and incubated in fresh William’s E medium with 5% fetal bovine serum (FBS) for 4 hr and there-
after, incubated in 0.1% FBS overnight. Next day, cells were washed twice and incubated with
DMEM without glucose (Invitrogen) supplemented with 10 mM HEPES in the presence of 2 mM
pyruvate, 2 mM glutamate and 20 mM glycerol for 4 hr. The glucose concentrations in the media
were determined by Amplex Red glucose/glucose oxidase assay system (Invitrogen).
Total protein extraction, immunoprecipitation and western blotting
Liver tissues were homogenized in cold lysis buffer containing 50 mM Tris-HCl (pH 7.4), 2 mM EGTA,
5 mM EDTA, 30 mM NaF, 10 mM Na3VO4, 10 mM Na4P2O7, 40 mM glycerophosphate, 1 % NP-40,
and 1% protease inhibitor cocktail. After ~20 min incubation under mild agitation in the cold, the
homogenates were centrifuged for 15 min at 9000 rpm to pellet cell debris, and protein concentra-
tions were determined by BCA. Finally, the samples were diluted in 5x Laemmli buffer and boiled for
5 min. The protein lysates were subjected to SDS-polyacrylamide gel electrophoresis, as previously
described (Arruda et al., 2014; Fu et al., 2012). The antibodies used in this study are listed in Table
2. All the immunoblots were incubated with primary antibody overnight at 4˚C, followed by incuba-
tion with secondary antibody conjugated with horseradish peroxidase (Amersham Biosciences) for 1–
3 hr at room temperature. Individual membranes were visualized using the enhanced chemilumines-
cence system (Roche Diagnostics). Immunoprecipitation (IP): For the immunoprecipitation studies,
primary antibodies against STIM1 and O-GlcNAc were cross-linked on to protein-A magnetic beads
with Dimethylpimelimidate (DMP). Cells lysates were prepared in a IP lysis buffer containing 50 mM
Tris-HCl (pH 7.4), 1 mM EDTA, 150 mM NaCl, 10 mM Na3VO4, 1 % NP-40, and 1% protease inhibitor
cocktail and 10 mM of PugNac. Protein content was adjusted to be the same in all samples and 300–
400 mg of protein were incubated with the beads overnight. The next day, samples were washed 3x
with IP buffer and eluted in Laemmli buffer and boiled for 5 min. Immunoblotting was performed as
described above. For the IP of Flag tagged STIM1, the lysates were incubated with anti-flag M2
magnetic beads from Sigma and eluted by competition with 3x flag peptide.
Gene expression analysis
Tissues in TRIzol (Invitrogen) were disrupted using TissueLyser (Qiagen). To obtain RNA, trizol homo-
genates were mixed with chloroform vortexed thoroughly and centrifuged 12000 g for 20 min at
4˚C. The top layer was transferred to another tube and mixed with isopropanol and centrifuged
again at 12000 g for 20 min at 4˚C. The RNA found in the precipitate was washed twice with 70%
Ethanol and diluted in RNAse free water. Complementary DNA was synthesized using iScript RT
Supermix kit (Biorad). Quantitative real-time PCR reactions were performed in duplicates or tripli-
cates on a ViiA7 system (Applied Biosystems) using SYBR green and custom primer sets or primer
sets based on Harvard primer bank. Gene of interest cycle thresholds (Cts) were normalized to 18S
ribosomal RNA (Rn18s) house keeper levels by the DDCt. The primers used for qPCR are listed in
Table 1.
Endogenous protein staining and confocal imaging
For thapsigargin (Tg) stimulation, primary hepatocytes or Hepa1-6 cells were seeded on 3.5 mm
round glass dishes (1.5 mm) in Williams Medium in the presence of 5% CCS overnight at 37˚C, 5%
CO2. The following morning, cells were washed, and in the afternoon they were incubated for a few
minutes in Ca2+-free medium (described in the Ca2+ imaging section) followed by 1 mM Tg treat-
ment (or vehicle, DMSO) for the duration indicated in the figure legends. Cells were fixed with 4%
paraformaldehyde for 10 min at room temperature (RT) and washed 3x in PBS, before a 20 min per-
meabilization using 0.2% Triton-X100 in 2% BSA at RT. Primary antibodies were diluted 1:200 for
STIM1 (Cell Signaling #4916), 1:100 for STIM2 (Cell Signaling #4917), for Na+/K+ ATPase a 1 -Alexa
Fluor 488 (Sigma #16–243) and for Anti-KDEL antibody, Alexa fluor 488 (Abcam, ab184819) in PBS
and the cells were incubated in this solution over night at 4˚C in the dark. The next day, cells were
washed 3x, including one long wash for more than 10 min. Secondary antibody was diluted 1:2500
in PBS, and the cells were incubated with it at RT for 1 hr in the dark. The cells were washed 3x,
including one long wash, and if needed, Hoechst was used as nuclear marker, diluted 1:1000 in PBS
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for 10 min at RT. For the experiments described in Figure 1—figure supplement 1D, Figure 1—
figure supplement 2A,B cells were imaged at the Confocal and Light Microscopy Core Facility at
the Dana Farber Cancer Institute with a Yokogawa CSU-X1 spinning disk confocal system (Andor
Technology, South Windsor, CT) with a Nikon Ti-E inverted microscope (Nikon Instruments, Melville,
NY), using a 60x or 100x Plan Apo objective lens with a Hamamatsu OrcaER camera. Andor iQ soft-
ware (Andor Technology, South Windsor, CT) was used for acquisition parameters, shutters, filter
positions and focus control. For Figures 1C, D, 3G and 5D, cells were imaged at the Harvard Medi-
cal School Imaging Core with a Yokogawa CSU-X1 spinning disk confocal system (Andor Technol-
ogy, South Windsor, CT) with an iXon EMCCD camera and Metamorph was the software used for
acquisition parameters, shutters, filter positions and focus control. For Figure 2H cells were image
with a Yokogawa CSU-X1 spinning disk confocal system (Andor Technology, South Windsor, CT)
with a Nikon Ti-E inverted microscope (Nikon Instruments, Melville, NY), using a 60x or 100x Plan
Apo objective lens with Zyla cMOS camera and NIS elements software was used for acquisition
parameters, shutters, filter positions and focus control.
Confocal image analysis
Image analysis was performed using Fiji software. All the images in the same experiment were ana-
lyzed using the same parameters. For Figure 1E, puncta number was counted using a custom made
macro. After background subtraction of 15, images were subject to ‘Filter Gaussian blur’ of 1.00 and
a threshold was set to define puncta from background signal. In order to localize the individual
puncta ‘Find Maxima’ tool was used and puncta were counted using ‘Analyze Particles’ tool. For
Figure 2J, images were background subtracted and single cells or groups of cells either expressing
OGT or not (identified by RFP expression), were cropped from the original image. Puncta above a
threshold of 50 were counted using ‘Analyze Particles’, and normalized to number of cells in the
field. Puncta pixel intensities: For Figure 1F and Figure 1—figure supplement 2B, a 125  125 pix-
els box was placed in a representative region of the cell and pixel intensities were recorded in the
entire box using a custom made macro. Intensities were distributed into a histogram with R, and
plotted in Prism. No further normalization was performed, as the same number of pixels was evalu-
ated in all the images.
Table 2. List of antibodies used in this study.
Antibodies used in western blots
Antibody Vendor Catalog number
STIM1 Cell signaling #4916
STIM2 Cell signaling #4917
ORAI1 Sigma SAB3500126
SERCA2b Cell Signaling #4388
pJNK Cell signaling #81E11
peIF2alpha Cell signaling #3597
CHOP Cell Signaling mab# 2895
pAKT Santa Cruz 7985R
AKT Santa Cruz 8312
IR Santa Cruz 711
pIR Calbiochem 407707
OGT Cell Signaling #5368
O-GlcNAc (CTD110.6) Cell Signaling #12938
Flag M2 Sigma SLBD9930
pCamKII Cell Signaling #12716
b-tubulin Abcam ab 21058
pSTIM1 provided by Dr. Martin-Romero, University of Extremadura, Spain
DOI: https://doi.org/10.7554/eLife.29968.028
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Plot profile in Figures 1G, 2L and 5E: A thin box of 40  250 pixels was placed across the cell
and the average intensity contained in the box was plotted as a profile with Fiji. Edge/cyto measure-
ments: for Figures 1H, 2N,5D, Figure 1—figure supplement 2B: A small box was hand-drawn at a
region of the edge of the cell (at the PM), and the same size box was placed right next to the edge,
in the cytoplasmic region. The mean STIM signal across each box was recorded, and the ratio
between the reading at the edge of the cell and in the cytoplasm was derived after background sig-
nal subtraction. Such pairs of boxes were drawn in four representative places in each cell, from 2 to
5 cells per field. Areas were chosen only on cell membranes containing neighbor cells.
Total internal reflection fluorescence (TIRF) microscopy
For the TIRF images, cells were stained as described above using anti-STIM1 antibody and anti-
Na+/K+ ATPase a 1, Alexa Fluor 488 antibody to stain the PM. In each experiment epifluorescence
images were acquired and the PM marker was used to define the PM area for the TIRF imaging. The
images were acquired a Zeiss Elyra PS.1 microscope with a 60 or 100  1.46 N.A. oil immersion TIRF
objective (Carl Zeiss GmbH, Germany) in TIRF mode with an Andor EM-CCD camera (512  512 pix-
els) at the Harvard center for Biological Imaging, Cambridge, MA.
Cytosolic Ca2+imaging using Fura-2 AM and Fluo-4
Cells were loaded with 4 mM Fura-2AM and 1 mM Pluronic F-127 in HBSS for ~60 min at room tem-
perature. Before imaging, the cells were washed and kept in a medium containing 10 mM Hepes,
150 mM NaCl, 4 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 mM D-glucose, pH 7.4. Ca
2+-free medium
was prepared similarly to the buffer described above, in the absence of CaCl2 and in the presence
of 2 mM EGTA and 3 mM MgCl2. Cells were stimulated with 1 mM Tg for indirect ER Ca
2+ measure-
ments, and in some cases supplemented with 100 mM 2-APB for SOCE inhibition. Ratiometric Fura-
2AM imaging was performed by alternatively illuminated with 340 and 380 nm light for 250 ms
(Lambda DG-4; Sutter Instrument Co.), using an Olympus IX70 with 40x objective. Emission
light >510 nm was captured using a CCD camera (Orca-ER; Hamamatsu Photonics). Both channels
were collected every 5 s, background corrected and analyzed with Slidebook and custom-made
R-scripts. For the Fluo-4 experiments described in Figure 2J, the same procedure described above
as used except that the cells were incubate with Fluo-4 for 30 min to 1 hr. The images were acquired
on a Leica SP8X and LAS X software was used for acquisition parameters, shutters, filter positions
and focus control.
Cell culture
Loss of function experiments were performed in Hepa1-6 cells (a mouse hepatocyte cell line from
ATCC, derivative of the BW7756 mouse hepatoma that arose in C57/L mouse) for STIM1, STIM2 and
ORAI1. This cell line was negative for mycoplasma testing. Five different shRNA sequences targeting
different regions of each gene were obtained from MISSION shRNA Library (Sigma) along with the
Scramble shRNA control. Stable cell lines were generated by lentiviral infection of Hepa1-6 cells
overnight in media (DMEM and 10% CCS and polybrene). After infection cells were incubated in
growth media (DMEM and 10% CCS) and selected with 3 mg/ml puromycine. The knockdown effi-
ciency of each shRNA was evaluated by western blot analysis and the experiments were done with
the sequence that generated the highest efficiency. Cells were frozen at passage two after selection
and fresh cells were thawed for each experiment. The sequences of the shRNA used in the study are
listed in Table 1. For the overexpression of OGT, a hOGT/RFP co-expression plasmid was generated
using a self-cleaving P2A peptide linker. RFP was first cloned into pcDNA6 Myc/His B (Life Technolo-
gies V22120) at BamHI/XhoI sites. OGT-P2A was generated by PCR (F: 5’-CCC GGT ACC GCC ACC
ATG GCGTCTTCCGTGGGCAA; R: 5’- CCC GGA TCC AGG TCC AGG GTT CTC CTC CAC GTC
TCC AGC CTG CTT CAG CAG GCT GAA GTT AGT AGC TCC GCT TCC TGCTGACTCAGTGACTTC
) and cloned into the above vector at KpnI/BamHI sites.The OGT-RFP plasmid was transfected into,
cells using lipofectamine 2000 overnight in OptiMEM media and the experiment done after 36–48 hr
after transfection. For the STIM1-flag pull downs, 3xFLAG-mSTIM1 was generated by PCR (F: 5’-
CCC GGATCC GCC ACC ATG GAC TAC AAA GAC CAT GAC GGT GAT TAT AAA GAT CAT GAC
ATC GAT TAC AAG GAT GAC GAT GAC AAG GATGTGTGCGCCCGTCTTGCCCTGT; R: 5’- CCC
GCGGCCGC TTA CTA CTTCTTAAGAGGCTTCTTAA) and cloned into pENTR1A no CCDB vector
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(Addgene #17398) at BamHI/NotI sites and then transferred to pLenti CMV Puro DEST (w118-1)
(Addgene # 17452) using Gateway LR Clonase II Enzyme Mix (Life Technologies 11791). STIM1-flag
was transfected in HEK293T cells and after 24–36 hours cells were trated with 3 ug/mL of puromycin
for selection and a stable cell line was generated.
Insulin treatment in vivo and in vitro and lipid loading
For insulin signaling studies, cells were serum deprived for 4 hr before stimulus with 3 nM of insulin
for 3 and 6 min. Cells were washed in ice-cold PBS and snap-frozen in liquid nitrogen. For the insulin
infusions in vivo, following 6 hr of food withdrawal, mice were anaesthetized with an intraperitoneal
injection of 2 mg/ml xylazine and 2 mg/ml ketamine, and insulin (0.75 IU kg 1) or phosphate buff-
ered saline (PBS) in 200 ml volume was infused into the portal vein. Three minutes after infusion, tis-
sues were removed and frozen in liquid nitrogen and kept at –80˚C until processing. For lipid
loading experiments primary hepatocytes were isolated in the morning and kept in Williams E
medium. After the cells were settled, Williams medium containing 1 mM Oleic acid and 40 mM pal-
mitic acid was added to the culture. Cells before and after 16 hr of lipid loading and stained with
BODIPY and Hoechst to visualize lipid droplets and nucleus, respectively.
Transmission electron microscopy (TEM)
For TEM, primary hepatocytes were fixed in a 1:1 ratio in a fixative buffer and Williams Medium. The
fixative buffer contained: 4 parts of FP stock (2.5% PFA, 0.06% picric acid in 0.2M Sodium Cacody-
late buffer pH 7.4) and 1 part of 25% glutaraldehyde for at least 2 hr. The samples were then placed
in propyleneoxide for 1 hr and infiltrated in a 1:1 mixture of propyleneoxide and TAAB 812 Resin
mixture (Marivac Canada Inc. St. Laurent, Canada). Sectioning and imaging: ultrathin sections (about
90 nm) were generated using a Reichert Ultracut-S microtome, JEOL microscope. Images were
recorded with an AMT 2 k CCD camera. For the STIM-HRP labeled cells, primary hepatocytes were
infected with adenovirus expressing STIM1-HRP. The construct was kindly provided by Dr. Lewis
from Stanford University and cloned in an adenovirus (serotype 5, Ad5). Primary hepatocytes were
fixed in a buffer containing 2% glutaraldehyde in 0.1 M sodium cacodylate at room temperature for
1 hr, then quickly moved to ice and washed with 0.1 M sodium cacodylate buffer for 10 min. HRP
was visualized with 0.5 mg ml diaminobenzidine and 0.03% hydrogen peroxide in 0.1 M sodium
cacodylate buffer for 5 min-20min. The reaction was stopped by five washes with cold 0.1 M sodium
cacodylate buffer.
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